New nanoparticle design inspires hopes of HIV cure
Researchers from the Peter Doherty Institute for Infection and Immunity in Melbourne have demonstrated a way to make HIV visible, paving the way to a complete cure.
In a paper published in Nature Communications, the scientists have shown for the first time that mRNA can be delivered into the cells where HIV is hiding using a new type of lipid nanoparticle (LNP).
The team developed an LNP formulation (LNP X) with unprecedented potency to deliver mRNA to hard-to-transfect resting CD4+ T cells in the absence of cellular toxicity or activation, where the mRNA prompts the cells to expose the dormant virus.
They say that LNP X enables the delivery of clustered regularly interspaced short palindromic repeats (CRISPR) activation machinery to modulate both viral and host gene transcription.
Dr Paula Cevaal, Research Fellow at the Doherty Institute and co-first author of the study, told The Guardian: “Our hope is that this new nanoparticle design could be a new pathway to an HIV cure. In terms of specifically the field of HIV cure, we have never seen anything close to as good as what we are seeing, in terms of how well we are able to reveal this virus. So from that point of view, we’re very hopeful that we are also able to see this type of response in an animal, and that we could eventually do this in humans.”
The paper concludes that the findings identify LNP X as a promising in vitro transfection tool that has the potential to replace nucleofection or viral transduction in the development of therapeutics for a range of T cell-implicated diseases or the generation of T cell-based immunotherapies.
The authors also state that the data justifies exploring LNP X for delivering nucleic acid cargo to other hard-to-transfect cell types.
DIANA SPENCER, Senior Digital Content Editor, DDW
